Short exposure to Notch ligand Delta-4 is sufficient to induce T-cell differentiation program and to increase the T cell potential of primary human CD34+ cells
Short exposure to Notch ligand Delta-4 is sufficient to induce T-cell differentiation program and to increase the T cell potential of primary human CD34+ cells
复制标题
DOI:
10.1016/j.exphem.2006.08.007
复制
发表时间:
2006-12-01
影响因子:
2.6
通讯作者:
Levy, Yves
中科院分区:
文献类型:
--
作者:
Lefort, Nathalie;Benne, Clarisse;Levy, Yves
Objective. The Notch pathway plays a key role in cell fate choices and in T-cell development. The goal of our study was to evaluate whether a short in vitro stimulation of the Notch pathway may alter human progenitor cell behavior.Methods. CD34(+) cord blood progenitors were exposed for 4 days to either immobilized Notch ligand Delta-4 or in control conditions. Phenotypic and molecular changes induced by the short stimulation were assessed at day 4. Next, long-term alteration of the fate of these progenitors was assessed in culture conditions suitable for B (coculture with MS5 stromal cells) and T (FTOC and OP9 stromal cells expressing Delta-4 systems) cell differentiation.Results. Notch activation was sufficient to trigger immunophenotypic and molecular changes consistent with early T-cell lineage differentiation. Delta-4 induced, in 4 days, CD+'cytCD3 epsilon(+) cells. This paralleled at the gene-transcription level with de novo expression of several T cell-related transcription factors and TCR gamma rearrangement, while B cell transcripts were simultaneous silenced. As compared to non-Delta-4 primed cells, these early changes translated to long-term alteration of the potential of cells. Delta-4 priming led to an acceleration of T-cell development, including a completion of the TCR rearrangement, when cells were cultured in systems suitable for T-cell development while B-cell development was inhibited.Conclusion. A transient Notch activation is sufficient to promote T-cell differentiation from cord blood CD34(+) cells. This system may be a useful tool for the amplification and the quantification of the T potential of CD34(+) cells in various disease conditions. (c) 2006 International Society for Experimental Hematology. Published by Elsevier Inc.